3T is an immunotherapy company developing next-generation, transformative therapies for the treatment of solid tumors and other immune-mediated diseases in broad patient populations. By leveraging the power of the immune system to recognize, target, and destroy cancer cells, 3T's technology is adva...See more
Headquarters:
United States of America
Company Type:
SME
Company size:
11-50 Employees
Year Founded:
2017 (8 years)
Address:
681 GATEWAY BLVD; SOUTH SAN FRANCISCO, CALIFORNIA 94080, US
LOW
spending power